| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00216-011-5098-9 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00216-011-5098-9 |
| P698 | PubMed publication ID | 21626193 |
| P2093 | author name string | Hao Wu | |
| Chunhui Deng | |||
| Huazong Zeng | |||
| Ruyi Xue | |||
| Xizhong Shen | |||
| Taotao Liu | |||
| Chunguang Ma | |||
| P2860 | cites work | Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression | Q24654019 |
| Cancer statistics, 2008 | Q27860585 | ||
| Chemometrics in metabonomics. | Q30359585 | ||
| NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate | Q30702501 | ||
| Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. | Q31137234 | ||
| Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis | Q33287430 | ||
| Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry | Q33435548 | ||
| Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours | Q34095870 | ||
| Metabonomics: a platform for studying drug toxicity and gene function | Q34139125 | ||
| Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter | Q34323096 | ||
| Metabolomics: available results, current research projects in breast cancer, and future applications. | Q34628323 | ||
| Role of the liver in the control of carbohydrate and lipid homeostasis | Q36020648 | ||
| Measuring the metabolome: current analytical technologies | Q36106252 | ||
| Urine markers in monitoring for prostate cancer. | Q37571461 | ||
| Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial | Q39752227 | ||
| TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro | Q39754644 | ||
| Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). | Q39907905 | ||
| Serum sarcosine is not a marker for prostate cancer | Q43127337 | ||
| Gas chromatography/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients | Q43292654 | ||
| Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry | Q43945230 | ||
| A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry | Q45014825 | ||
| Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. | Q45925784 | ||
| Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. | Q46003361 | ||
| The profile of prostate epithelial cytokines and its impact on sera prostate specific antigen levels | Q46315125 | ||
| Development of microwave-assisted derivatization followed by gas chromatography/mass spectrometry for fast determination of amino acids in neonatal blood samples | Q46599303 | ||
| Metabolomic profiling to develop blood biomarkers for Parkinson's disease | Q46789088 | ||
| Simultaneous determination of blood glucose and isoleucine levels in rats after chronic alcohol exposure by microwave-assisted derivatization and isotope dilution gas chromatography/mass spectrometry. | Q46846409 | ||
| Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for "in competition" anti-doping analysis | Q46848468 | ||
| Extraction and GC/MS analysis of the human blood plasma metabolome | Q46849028 | ||
| Metabolomics identifies perturbations in human disorders of propionate metabolism | Q46939247 | ||
| Classification of toxin-induced changes in 1H NMR spectra of urine using an artificial neural network. | Q52349642 | ||
| Acute biochemical effects of La(NO3)3 on liver and kidney tissues by magic-angle spinning 1H nuclear magnetic resonance spectroscopy and pattern recognition | Q57100340 | ||
| NMR-based metabonomic toxicity classification: hierarchical cluster analysis and k-nearest-neighbour approaches | Q58046056 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microwave | Q127995 |
| biomarker | Q864574 | ||
| prostate cancer | Q181257 | ||
| P304 | page(s) | 635-646 | |
| P577 | publication date | 2011-05-29 | |
| P1433 | published in | Analytical and Bioanalytical Chemistry | Q2845280 |
| P1476 | title | GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization | |
| P478 | volume | 401 |
| Q60950173 | A Rapid Method for the Detection of Sarcosine Using SPIONs/Au/CS/SOX/NPs for Prostate Cancer Sensing |
| Q35796351 | A case control study of sarcosine as an early prostate cancer detection biomarker |
| Q44632211 | A strategy to decorate porous polymer monoliths with graphene oxide and graphene nanosheets |
| Q37612851 | Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study. |
| Q46592073 | An organic indicator functionalized graphene oxide nanocomposite-based colorimetric assay for the detection of sarcosine |
| Q28534070 | Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery |
| Q35234286 | Application of metabolomics to prostate cancer |
| Q91100157 | Approaches to urinary detection of prostate cancer |
| Q26738585 | Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies |
| Q36228895 | Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling |
| Q92052827 | Cancer metabolomic markers in urine: evidence, techniques and recommendations |
| Q53965381 | Derivatization coupled to headspace programmed-temperature vaporizer gas chromatography with mass spectrometry for the determination of amino acids: Application to urine samples. |
| Q40092504 | Detecting serum and urine metabolic profile changes of CCl4-liver fibrosis in rats at 12 weeks based on gas chromatography-mass spectrometry |
| Q55070678 | Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS. |
| Q40047134 | Dupuytren's disease metabolite analyses reveals alterations following initial short-term fibroblast culturing |
| Q42679542 | Effects of Shu Gan Jian Pi formula on rats with carbon tetrachloride‑induced liver fibrosis using serum metabonomics based on gas chromatography‑time of flight mass spectrometry |
| Q39450826 | Exploration of candidate biomarkers for human psoriasis based on gas chromatography-mass spectrometry serum metabolomics |
| Q58086223 | Flow Injection-Traveling Wave Ion Mobility-Mass Spectrometry for Rapid Prostate Cancer Metabolomics |
| Q64098948 | For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects |
| Q52347460 | GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells. |
| Q64230664 | GC/MS-Based Metabolomics Approach to Evaluate the Effect of Jackyakgamcho-Tang on Acute Colitis |
| Q52620491 | Gas chromatography-time of flight/mass spectrometry-based metabonomics of changes in the urinary metabolic profile in osteoarthritic rats. |
| Q91211251 | Improving diagnosis of genitourinary cancers: Biomarker discovery strategies through mass spectrometry-based metabolomics |
| Q55282801 | Innovative Diagnostic Methods for Early Prostate Cancer Detection through Urine Analysis: A Review. |
| Q36643998 | Mechanism of Xinfeng Capsule on Adjuvant-Induced Arthritis via Analysis of Urinary Metabolomic Profiles |
| Q36254528 | Metabolic alterations in the sera of Chinese patients with mild persistent asthma: a GC-MS-based metabolomics analysis |
| Q31143019 | Metabolic characterization of the early stage of hepatic fibrosis in rat using GC-TOF/MS and multivariate data analyses |
| Q46291182 | Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond |
| Q38838580 | Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence |
| Q36949577 | Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry |
| Q28084834 | Metabolomic profiling of hormone-dependent cancers: a bird's eye view |
| Q64230297 | Metabolomics Biomarkers of Prostate Cancer: A Systematic Review |
| Q64116646 | Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers |
| Q38212626 | Metabolomics approaches and applications in prostate cancer research |
| Q59622191 | Metabolomics of diet-related diseases using mass spectrometry |
| Q51530672 | Microfluidic chip coupled with modified paramagnetic particles for sarcosine isolation in urine. |
| Q62399516 | Post-treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer |
| Q37205856 | Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
| Q50057843 | Prostate cancer diagnosis and characterization with mass spectrometry imaging. |
| Q92875395 | Review and Comparison of Cancer Biomarker Trends in Urine as a Basis for New Diagnostic Pathways |
| Q37091881 | Sarcosine as a potential prostate cancer biomarker--a review |
| Q54508449 | Sensitive determination of the potential biomarker sarcosine for prostate cancer by LC-MS with N,N'-dicyclohexylcarbodiimide derivatization. |
| Q38014695 | Serum metabolomics as a novel diagnostic approach for disease: a systematic review |
| Q57999041 | Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml |
| Q39411120 | Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer |
| Q64119574 | Simultaneous determination of sarcosine and its related metabolites by gas chromatography-tandem mass spectrometry for prostate cancer diagnosis |
| Q38939451 | The Role of Sarcosine, Uracil, and Kynurenic Acid Metabolism in Urine for Diagnosis and Progression Monitoring of Prostate Cancer. |
| Q35849909 | Urinary Volatile Organic Compounds for the Detection of Prostate Cancer |
| Q34750733 | Urine metabolic profile changes of CCl4-liver fibrosis in rats and intervention effects of Yi Guan Jian Decoction using metabonomic approach |
Search more.